Yu Jin Jang

Title: Innovations by Yu Jin Jang in Liver Fibrosis Treatment

Introduction

Yu Jin Jang is an accomplished inventor based in Seoul, South Korea. She has made significant contributions to the field of medical research, particularly in the treatment of liver fibrosis. Her innovative work focuses on utilizing exosomes and ribonucleic acids to develop therapeutic agents.

Latest Patents

Yu Jin Jang holds a patent for a composition aimed at preventing or treating liver fibrosis. The patent, titled "Composition for preventing or treating liver fibrosis, containing exosome or exosome-derived ribonucleic acid," describes a therapeutic agent that effectively inhibits the activities of hepatic stellate cells and Kupffer cells. This invention reduces the expression of α-SMA and inhibits collagen deposition, making it a promising candidate for liver fibrosis treatment.

Career Highlights

Yu Jin Jang is affiliated with the Korea University Research and Business Foundation, where she continues her research and development efforts. Her work has garnered attention for its potential impact on liver disease therapies.

Collaborations

Some of her notable coworkers include Jae Sang Hong and Do Hoon Lee, who contribute to her research initiatives.

Conclusion

Yu Jin Jang's innovative approach to treating liver fibrosis through exosome-derived therapies showcases her dedication to advancing medical science. Her contributions are paving the way for new treatment options in the field of liver health.